AbbVie’s Skyrizi nabs psoriatic arthritis nod, its second, shortly after Rinvoq fkansteiner Mon, 01/24/2022 – 09:03

With omicron on the prowl, FDA extends inspection pause into February fkansteiner Mon, 01/24/2022 – 10:01

Gilead pulls 2 cancer accelerated approvals as changing lymphoma landscape disrupts confirmatory trial aliu Mon, 01/24/2022 – 11:34

This editorial by Peter Doshi and colleagues (BMJ 2022;376:o102, doi:10.1136/bmj.o102) originally stated that the Medicines and Healthcare Products Regulatory Agency (MHRA) […]

Less selling, more science can best help doctors navigate complex new cancer treatments, report suggests nmissakian Sun, 01/23/2022 […]

Updated Date: Fri, 14 Jan 2022 00:00:00 EST

New MRI technology, developed by Siemens in collaboration with researchers at The Ohio State University College of Medicine […]

It is important that multiple sclerosis is diagnosed and treated as early as possible in order to delay […]

Evie Toombes seems to be an extraordinary person who has achieved so much in life despite substantial obstacles. […]

Fierce Pharma Asia—Lilly-Abbisko cardiometabolic pact; Daiichi Sankyo asset sale; Eisai’s next Alzheimer’s prospect aliu Fri, 01/21/2022 – 06:45